Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study (SUSUGUT)

January 28, 2022 updated by: University of Ulster

Unhealthy diets are closely linked to non-communicable diseases and constitute higher risk of morbidity and mortality than unsafe sex, alcohol, tobacco and drugs use combined. According to the World Health Organization (WHO), a healthy diet follows a plant-based pattern with low quantities of red meat and a low simple sugar intake. It would also reduce anthropological ecologic impact. We hypothesize that a plant-based diet will beneficially modify the gut microbiota and metabolome, influencing also Trimethylamine N-oxide (TMAO), a metabolite associated to CVD.

This study has a randomized single blind crossover design that compares a plant-based diet towards a control western diet. It is applied to volunteers aged 18-70 years, N=20. Each dietary intervention (plant-based and western) would last for 16 consecutive days separated by a minimum of 7 weeks washout period (intervention 1-washout-intervention 2). Samples of blood urine and faeces will be collected at day 1 and 14 of each intervention. On day 14 will be performed L-carnitine challenge with 1200mg of L-carnitine to test the levels of TMAO), in for the next 2 consecutive days (24h and 48h post treatment).

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Londonderry
      • Coleraine, Londonderry, United Kingdom, BT52 1SA
        • Human Intervention Studies Unit, Ulster University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Free-living, apparently healthy adults
  • Bmi>18
  • Aged 18-70 years at recruitment
  • Non-smokers

Exclusion criteria:

  • Non-free-living adults
  • Adults <18 or >70 years at recruitment
  • BMI<18
  • Current smokers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Plant-based diet
Diet rich in fruit and vegetables (42% carbohydrates, 17.2% fibres; 15% proteins and 43% fats).
16 days with all foods provided
Active Comparator: Active Comparator: Western diet
Diet Rich in Processed Foods (48% carbohydrates, 10.4% fibres; 14% proteins and 39% fats).
16 days with all foods provided

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gut microbiota changes
Time Frame: Change over 14 days
Significant changes in the number of bifidobacteria
Change over 14 days
Quantification of Trimethylamine N-oxide
Time Frame: Day 16
Changes in response to L-Carnitine challenge
Day 16

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bioactivity of faecal water
Time Frame: Change over 14 days
Measured by using faecal water as basis for growth media (ex vivo measure)
Change over 14 days
Effects on inflammatory markers of both diets
Time Frame: Change over 14 days
Cytokine analysis via ELISA test (MagPix)
Change over 14 days
Ex vivo effects of faecal water on gut pathobionts
Time Frame: Day 14
Co-culturing the aqueous phase of faeces with C. difficile to assess changes in its biology
Day 14
Quantification of phytochemicals
Time Frame: Change over 14 days
Measured by LC-MS
Change over 14 days
Quantification of Short Chain Fatty Acids (SCFA)
Time Frame: Change over 14 days
Measured by nuclear magnetic resonance (NMR)
Change over 14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 2, 2021

Primary Completion (Actual)

December 17, 2021

Study Completion (Actual)

December 17, 2021

Study Registration Dates

First Submitted

January 28, 2022

First Submitted That Met QC Criteria

January 28, 2022

First Posted (Actual)

February 9, 2022

Study Record Updates

Last Update Posted (Actual)

February 9, 2022

Last Update Submitted That Met QC Criteria

January 28, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Microbiota

Clinical Trials on Plant-based diet

3
Subscribe